Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.

about

Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.Reprogramming the metabolome rescues retinal degeneration.

P2860

Q37452246-4CE768EC-F286-4FC3-ACB1-610ECA144E15 Q48248144-14AF71D2-15A9-4B57-8403-C0AD2FC94F00

P2860

Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.

Item

http://www.wikidata.org/entity/Q41643467

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Reprogramming towards anabolis ...... model of retinitis pigmentosa.

@en

type

Item

label

Reprogramming towards anabolis ...... model of retinitis pigmentosa.

@en

prefLabel

Reprogramming towards anabolis ...... model of retinitis pigmentosa.

@en

P1476

Reprogramming towards anabolis ...... model of retinitis pigmentosa.

@en

P2093

Alexander G Bassuk

http://www.w3.org/2001/XMLSchema#string

Chun-Wei Hsu

http://www.w3.org/2001/XMLSchema#string

Chyuan-Sheng Lin

http://www.w3.org/2001/XMLSchema#string

Jimmy K Duong

http://www.w3.org/2001/XMLSchema#string

Jin Yang

http://www.w3.org/2001/XMLSchema#string

Lijuan Zhang

http://www.w3.org/2001/XMLSchema#string

Sally Justus

http://www.w3.org/2001/XMLSchema#string

Stephen H Tsang

http://www.w3.org/2001/XMLSchema#string

Tamara Pluchenik

http://www.w3.org/2001/XMLSchema#string

Vinit B Mahajan

http://www.w3.org/2001/XMLSchema#string

P2860

Retinitis pigmentosa

Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders

Biology and therapy of inherited retinal degenerative disease: insights from mouse models

A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

The Roles of mTOR Complexes in Lipid Metabolism

Prevalence of age-related macular degeneration in the United States

Retinitis pigmentosa

Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.

Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families

P304

4244-4255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDW256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27516389

http://www.w3.org/2001/XMLSchema#string

P932

5291198

http://www.w3.org/2001/XMLSchema#string

Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.

about

P2860

P2860

Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932